دورية أكاديمية

Epithelial cell adhesion molecule (EPCAM) is an independent prognostic marker in clear cell renal carcinoma

التفاصيل البيبلوغرافية
العنوان: Epithelial cell adhesion molecule (EPCAM) is an independent prognostic marker in clear cell renal carcinoma
المؤلفون: Eichelberg, Christian, Chun, Felix K, Bedke, Jens, Heuer, Roman, Adam, Meike, Moch, Holger, Terracciano, Luigi, Hinrichs, Kristin, Dahlem, Roland, Fisch, Margit, Schlomm, Thorsten, Sauter, Guido, Minner, Sarah
المصدر: Eichelberg, Christian; Chun, Felix K; Bedke, Jens; Heuer, Roman; Adam, Meike; Moch, Holger; Terracciano, Luigi; Hinrichs, Kristin; Dahlem, Roland; Fisch, Margit; Schlomm, Thorsten; Sauter, Guido; Minner, Sarah (2013). Epithelial cell adhesion molecule (EPCAM) is an independent prognostic marker in clear cell renal carcinoma. International journal of cancer. Journal international du cancer, 132(12):2948-2955.
بيانات النشر: Wiley-Blackwell
سنة النشر: 2013
المجموعة: University of Zurich (UZH): ZORA (Zurich Open Repository and Archive
مصطلحات موضوعية: Institute of Pathology and Molecular Pathology, 610 Medicine & health
الوصف: Epithelial cell adhesion molecule (EPCAM) has recently attained a renewed interest as a candidate protein in diagnosis, prognostication and therapy of various tumor entities. The molecular epidemiology and prognostic relevance of EPCAM in renal cell carcinoma (RCC) and amongst the histological subtypes of RCC is unclear. We analyzed the prevalence and prognostic significance of EPCAM in a tumor tissue micro-array (TMA) composed of 1088 independent RCCs samples by immunohistochemistry (IHC). We found significant variations of EPCAM IHC staining intensities in between the RCC subtypes: In papillary and chromophobe RCC, the majority of tumors (89-93%) showed an at least weak EPCAM protein expression. In the largest subgroup, the clear cell (cc)RCC (n=767), a negative EPCAM IHC was found in 1/3 of the patients and was associated with high-grade disease and nodal metastases. Kaplan-Meier analyses demonstrated a significant association between positive EPCAM IHC and prolonged overall survival, even in a subset of low risk ccRCC. In multivariable analyses, EPCAM represented an independent risk factor of survival throughout all subgroups. For localized, low-grade ccRCC, information of EPCAM IHC raised predictive accuracy of a multivariate model by ∼5%, compared to T-stage and grade alone. Our findings indicate, that EPCAM is an independent prognostic molecular marker in ccRCC and, especially in localized ccRCC, might be able to provide auxiliary information for a better prognostication.
نوع الوثيقة: article in journal/newspaper
وصف الملف: application/pdf
اللغة: English
تدمد: 0020-7136
العلاقة: https://www.zora.uzh.ch/id/eprint/67519/1/Eichelberg_IJCancer_2012.pdfTest; info:pmid/23180689; urn:issn:0020-7136
DOI: 10.5167/uzh-67519
DOI: 10.1002/ijc.27970
الإتاحة: https://doi.org/10.5167/uzh-6751910.1002/ijc.27970Test
https://www.zora.uzh.ch/id/eprint/67519Test/
https://www.zora.uzh.ch/id/eprint/67519/1/Eichelberg_IJCancer_2012.pdfTest
حقوق: info:eu-repo/semantics/openAccess
رقم الانضمام: edsbas.9018A8AF
قاعدة البيانات: BASE
الوصف
تدمد:00207136
DOI:10.5167/uzh-67519